{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:17:15Z","timestamp":1776338235419,"version":"3.51.2"},"reference-count":33,"publisher":"Japanese Society of Toxicology","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2020]]},"DOI":"10.2131\/jts.45.701","type":"journal-article","created":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T22:06:37Z","timestamp":1604268397000},"page":"701-711","source":"Crossref","is-referenced-by-count":9,"title":["PD-1\/PD-L1 affects Graves progression through lymphocytes on the proliferation, apoptosis and inflammatory cytokine secretion of thyroid follicular epithelial cells"],"prefix":"10.2131","volume":"45","author":[{"given":"Hui","family":"Han","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodan","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez-Sierra, D., Mar\u00edn-S\u00e1nchez, A., Ruiz-Bl\u00e1zquez, P., de Jes\u00fas Gil, C., Iglesias-Felip, C., Gonz\u00e1lez, \u00d3., Casteras, A., Costa, R.F., Nuciforo, P., Colobran, R. and Pujol-Borrell, R. (2019): Analysis of the PD-1\/PD-L1 axis in human autoimmune thyroid disease: insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity. J. Autoimmun., <b>103<\/b>, 102285.","DOI":"10.1016\/j.jaut.2019.05.013"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Ansari, M.J., Salama, A.D., Chitnis, T., Smith, R.N., Yagita, H., Akiba, H., Yamazaki, T., Azuma, M., Iwai, H., Khoury, S.J., Auchincloss, H. Jr. and Sayegh, M.H. (2003): The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med., <b>198<\/b>, 63-69.","DOI":"10.1084\/jem.20022125"},{"key":"3","unstructured":"Baral, S., Shrestha, P.K. and Pant, V. (2017): Serum Free T<sub>3<\/sub> to Free T<sub>4<\/sub> Ratio as a Useful Indicator for Differentiating Destruction Induced Thyrotoxicosis from Graves\u2019 Disease. J. Clin. Diagn. Res., <b>11<\/b>, OC12-OC14."},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bossowski, A., Urban, M. and Stasiak-Barmuta, A. (2003): Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases. J. Pediatr. Endocrinol. Metab., <b>16<\/b>, 63-70.","DOI":"10.1515\/JPEM.2003.16.1.63"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chiaravalloti, A., Ursini, F., Fiorentini, A., Barbagallo, G., Martorana, A., Koch, G., Tavolozza, M. and Schillaci, O. (2017): Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: a F-18 FDG PET\/CT study. Sci. Rep., <b>7<\/b>, 6220.","DOI":"10.1038\/s41598-017-06138-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Collins, M., Michot, J.M., Danlos, F.X., Mussini, C., Soularue, E., Mateus, C., Loirat, D., Buisson, A., Rosa, I., Lambotte, O., Laghouati, S., Chaput, N., Coutzac, C., Voisin, A.L., Soria, J.C., Marabelle, A., Champiat, S., Robert, C. and Carbonnel, F. (2017): Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies. Ann. Oncol., <b>28<\/b>, 2860-2865.","DOI":"10.1093\/annonc\/mdx403"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Coomans de Brach\u00e8ne, A., Dos Santos, R.S., Marroqui, L., Colli, M.L., Marselli, L., Mirmira, R.G., Marchetti, P. and Eizirik, D.L. (2018): IFN-\u03b1 induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells. Diabetologia, <b>61<\/b>, 636-640.","DOI":"10.1007\/s00125-017-4536-4"},{"key":"8","unstructured":"Cox, S.C., Tamatea, J.A., Conaglen, J.V. and Elston, M.S. (2016): The management of Graves\u2019 disease in New Zealand 2014. N. Z. Med. J., <b>129<\/b>, 10-24."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Dai, S., Jia, R., Zhang, X., Fang, Q. and Huang, L. (2014): The PD-1\/PD-Ls pathway and autoimmune diseases. Cell. Immunol., <b>290<\/b>, 72-79.","DOI":"10.1016\/j.cellimm.2014.05.006"},{"key":"10","unstructured":"DeGroot, L.J. (2000): Graves\u2019 Disease and the Manifestations of Thyrotoxicosis. In: Endotext (Feingold, K.R., Anawalt, B., Boyce, A. <i>et al<\/i>. eds.), MDText.com, Inc., South Dartmouth (MA)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"Dong, Q., Liu, X., Wang, F., Xu, Y., Liang, C., Du, W. and Gao, G. (2017): Dynamic changes of TRAb and TPOAb after radioiodine therapy in Graves\u2019 disease. Acta Endocrinol. (Bucur.), <b>13<\/b>, 72-76.","DOI":"10.4183\/aeb.2017.72"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Feng, M., Xiong, G., Cao, Z., Yang, G., Zheng, S., Song, X., You, L., Zheng, L., Zhang, T. and Zhao, Y. (2017): PD-1\/PD-L1 and immunotherapy for pancreatic cancer. Cancer Lett., <b>407<\/b>, 57-65.","DOI":"10.1016\/j.canlet.2017.08.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Jeker, L.T., Hejazi, M., Burek, C.L., Rose, N.R. and Caturegli, P. (1999): Mouse thyroid primary culture. Biochem. Biophys. Res. Commun., <b>257<\/b>, 511-515.","DOI":"10.1006\/bbrc.1999.0468"},{"key":"14","unstructured":"Jin, H.T., Ahmed, R. and Okazaki, T. (2011): Role of PD-1 in regulating T-cell immunity. Curr. Top. Microbiol. Immunol., <b>350<\/b>, 17-37."},{"key":"15","doi-asserted-by":"crossref","unstructured":"Josephs, T.M., Grant, E.J. and Gras, S. (2017): Molecular challenges imposed by MHC-I restricted long epitopes on T cell immunity. Biol. Chem., <b>398<\/b>, 1027-1036.","DOI":"10.1515\/hsz-2016-0305"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Keir, M.E., Liang, S.C., Guleria, I., Latchman, Y.E., Qipo, A., Albacker, L.A., Koulmanda, M., Freeman, G.J., Sayegh, M.H. and Sharpe, A.H. (2006): Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med., <b>203<\/b>, 883-895.","DOI":"10.1084\/jem.20051776"},{"key":"17","first-page":"1013","year":"2007","unstructured":"Khoo, T.K. and Bahn, R.S. (2007): Pathogenesis of Graves\u2019 ophthalmopathy: the role of autoantibodies. Thyroid, <b>17<\/b>, 1013-1018.","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Kumata, K., Nagata, K., Matsushita, M., Kuwamoto, S., Kato, M., Murakami, I., Fukata, S. and Hayashi, K. (2016): Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves\u2019 Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein-Barr Virus Reactivation. Viral Immunol., <b>29<\/b>, 459-463.","DOI":"10.1089\/vim.2016.0043"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Liang, S.C., Latchman, Y.E., Buhlmann, J.E., Tomczak, M.F., Horwitz, B.H., Freeman, G.J. and Sharpe, A.H. (2003): Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol., <b>33<\/b>, 2706-2716.","DOI":"10.1002\/eji.200324228"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Louis-Dit-Sully, C., Blumenthal, B., Duchniewicz, M., Beck-Garcia, K., Fiala, G.J., Beck-Garc\u00eda, E., Mukenhirn, M., Minguet, S. and Schamel, W.W. (2014): Activation of the TCR complex by peptide-MHC and superantigens. Exp Suppl, <b>104<\/b> (Suppl 104), 9-23.","DOI":"10.1007\/978-3-0348-0726-5_2"},{"key":"21","doi-asserted-by":"publisher","unstructured":"McLeod, D.S. and Cooper, D.S. (2012): The incidence and prevalence of thyroid autoimmunity. Endocrine, <b>42<\/b>, 252-265.","DOI":"10.1007\/s12020-012-9703-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Prado-Garcia, H., Romero-Garcia, S., Puerto-Aquino, A. and Rumbo-Nava, U. (2017): The PD-L1\/PD-1 pathway promotes dysfunction, but not \u201cexhaustion\u201d, in tumor-responding T cells from pleural effusions in lung cancer patients. Cancer Immunol. Immunother., <b>66<\/b>, 765-776.","DOI":"10.1007\/s00262-017-1979-x"},{"key":"23","first-page":"73","year":"2018","unstructured":"Salmaninejad, A., Khoramshahi, V., Azani, A., Soltaninejad, E., Aslani, S., Zamani, M.R., Zal, M., Nesaei, A. and Hosseini, S.M. (2018): PD-1 and cancer: molecular mechanisms and polymorphisms. Immunogenetics, <b>70<\/b>, 73-86.","journal-title":"Immunogenetics","ISSN":"https:\/\/id.crossref.org\/issn\/0093-7711","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Saxena, P., Charpin-El Hamri, G., Folcher, M., Zulewski, H. and Fussenegger, M. (2016): Synthetic gene network restoring endogenous pituitary-thyroid feedback control in experimental Graves\u2019 disease. Proc. Natl. Acad. Sci. USA, <b>113<\/b>, 1244-1249.","DOI":"10.1073\/pnas.1514383113"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Shen, J., Li, Z., Li, W., Ge, Y., Xie, M., Lv, M., Fan, Y., Chen, Z., Zhao, D. and Han, Y. (2015): Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy. Dis. Markers, <b>2015<\/b>, 609593.","DOI":"10.1155\/2015\/609593"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Wang, J., Yoshida, T., Nakaki, F., Hiai, H., Okazaki, T. and Honjo, T. (2005): Establishment of NOD-Pdcd1-\/- mice as an efficient animal model of type I diabetes. Proc. Natl. Acad. Sci. USA, <b>102<\/b>, 11823-11828.","DOI":"10.1073\/pnas.0505497102"},{"key":"27","first-page":"68","year":"2018","unstructured":"Xu-Monette, Z.Y., Zhou, J. and Young, K.H. (2018): PD-1 expression and clinical PD-1 blockade in B-cell lymphomas. Blood, <b>131<\/b>, 68-83.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Ying, H., Tang, Y.P., Bao, Y.R., Su, X.J., Cai, X., Li, Y.H. and Wang, D.F. (2016): Maternal TSH level and TPOAb status in early pregnancy and their relationship to the risk of gestational diabetes mellitus. Endocrine, <b>54<\/b>, 742-750.","DOI":"10.1007\/s12020-016-1022-6"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Yu, T., Tian, C., Song, J., He, D., Wu, J., Wen, Z., Sun, Z. and Sun, Z. (2018): Value of the fT3\/fT4 ratio and its combination with the GRACE risk score in predicting the prognosis in euthyroid patients with acute myocardial infarction undergoing percutaneous coronary intervention: a prospective cohort study. BMC Cardiovasc. Disord., <b>18<\/b>, 181.","DOI":"10.1186\/s12872-018-0916-z"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Yuan, Q., Zhao, Y., Zhu, X. and Liu, X. (2017): Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves\u2019 disease model. J. Endocrinol. Invest., <b>40<\/b>, 397-407.","DOI":"10.1007\/s40618-016-0575-9"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Yunis, J., Farrell, H.E., Bruce, K., Lawler, C., Sidenius, S., Wyer, O., Davis-Poynter, N. and Stevenson, P.G. (2018): Murine cytomegalovirus degrades MHC class II to colonize the salivary glands. PLoS Pathog., <b>14<\/b>, e1006905.","DOI":"10.1371\/journal.ppat.1006905"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Zamani, M.R., Aslani, S., Salmaninejad, A., Javan, M.R. and Rezaei, N. (2016): PD-1\/PD-L and autoimmunity: A growing relationship. Cell. Immunol., <b>310<\/b>, 27-41.","DOI":"10.1016\/j.cellimm.2016.09.009"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Zloza, A., Jagoda, M.C., Lyons, G.E., Graves, M.C., Kohlhapp, F.J., O\u2019Sullivan, J.A., Lacek, A.T., Nishimura, M.I. and Guevara-Pati\u00f1o, J.A. (2011): CD8 co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-\u03b2 (TGF-\u03b2)-mediated suppression. Cancer Immunol. Immunother., <b>60<\/b>, 291-297.","DOI":"10.1007\/s00262-010-0962-6"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/45\/11\/45_701\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T03:31:23Z","timestamp":1604719883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/45\/11\/45_701\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.45.701","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}